Vimarsana
Biggest News Aggregation in the World

Page 38 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

Mandy Moore reveals 'resilient' son has rare skin condition - Vimarsana News

Mandy Moore reveals 'resilient' son has rare skin condition

Mandy Moore and Taylor Goldsmith's 2-year-old, August, has developed a "crazy rash" due to Gianotti Crosti syndrome, the actress shared on Instagram.

Harvard researchers develop ink that enables 3D printing of beating heart tissues - Vimarsana News

Harvard researchers develop ink that enables 3D printing of beating heart tissues

Over the last decade, advances in 3D printing have unlocked new possibilities for bioengineers to build heart tissues and structures.

Fiber-infused ink enables 3D-printed heart mu - Vimarsana News

Fiber-infused ink enables 3D-printed heart mu

Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) report the development of a new hydrogel ink infused with gelatin fibers that enables 3D printing of a functional heart ventricle that mimics beating like a human heart. They discovered the fiber-infused gel (FIG) ink allows heart muscle cells printed in the shape of a ventricle to align and beat in coordination like a human heart chamber.

Study reveals key mechanism linking obstructive sleep apnea and cardiovascular disease - Vimarsana News

Study reveals key mechanism linking obstructive sleep apnea and cardiovascular disease

Researchers have found that people with obstructive sleep apnea have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by interrupted breathing.

ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates - Vimarsana News

ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

TORONTO - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel biological therapeutics, announced today a...